We are live on
!
Find out more
MLA
MB, Levis & Associates Portfolio holdings
AUM
$271M
1-Year Est. Return
15.56%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+15.56%
3 Year Est. Return
+39.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$12.6M
(+6.6%)
Cap. Flow
+$1.72M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
65.14%
Holding
299
New
10
Increased
109
Reduced
22
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBDZ
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
|
+$12.6M |
| 2 |
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
|
+$254K |
| 3 |
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
|
+$210K |
| 4 |
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
|
+$186K |
| 5 |
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
|
+$181K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
|
+$12.1M |
| 2 |
Zebra Technologies
ZBRA
|
+$124K |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$113K |
| 4 |
WisdomTree US High Dividend Fund
DHS
|
+$78.5K |
| 5 |
American Century US Quality Growth ETF
QGRO
|
+$59.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.36% |
| 2 | Healthcare | 4.82% |
| 3 | Industrials | 4.74% |
| 4 | Financials | 3.11% |
| 5 | Consumer Staples | 3.05% |
Similar funds
S
TP
FCMV
MAM
MLM
MCM
SC
RP
MB, Levis & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, MB, Levis & Associates held 299 positions worth $203M, up 6.6% from $190M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
MB, Levis & Associates's Q3 2024 filing shows 10 new, 109 increased, 22 reduced and 7 closed positions. Its largest new stake was iShares iBonds Dec 2034 Term Corporate ETF: 481,773 shares worth $12.9M. The largest sale was iShares iBonds Dec 2029 Term Corporate ETF, an estimated $12.1M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.8% a quarter earlier, followed by Healthcare and Industrials.
- MB, Levis & Associates's largest Q3 2024 buy was iShares iBonds Dec 2034 Term Corporate ETF: 481,773 shares worth $12.9M.
- MB, Levis & Associates added most to iShares iBonds Dec 2032 Term Corporate ETF in Q3 2024, an estimated $254K increase.
- MB, Levis & Associates's biggest Q3 2024 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $113K.
- MB, Levis & Associates fully exited iShares iBonds Dec 2029 Term Corporate ETF in Q3 2024, selling an estimated $12.1M.
- MB, Levis & Associates's ten largest holdings make up 65% of its $203M portfolio in Q3 2024.
- MB, Levis & Associates opened 10 new positions and closed 7 in Q3 2024.
- MB, Levis & Associates's portfolio value rose 6.6% quarter-over-quarter to $203M.
Based on MB, Levis & Associates's 13F filing for Q3 2024, filed 7 May 2025.